Efficacy and Safety of 1‐L Polyethylene Glycol With Low Ascorbic Acid for Bowel Preparation: A Randomized Clinical Trial
- 30 September 2026
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 41 (11) , 3442-3450
Abstract
Background and Aims: Ultra‐low‐volume polyethylene glycol (PEG) with ascorbic acid (Asc) improves tolerability, but Asc‐related gastrointestinal and metabolic adverse events remain a concern. Whether reducing the Asc dose preserves cleansing efficacy without compromising safety is unclear. We compared a modified 1‐L PEG regimen with reduced Asc (1‐L PEG + low Asc) with standard 1‐L PEG + Asc and 2‐L PEG + Asc formulations. Methods: In this multicenter, randomized, investigator‐blinded, three‐arm noninferiority trial across five hospitals, low‐risk adults undergoing colonoscopy were allocated (1:1:1) to 1‐L PEG + low Asc, 1‐L PEG + Asc, or 2‐L PEG + Asc. The primary endpoint was successful bowel cleansing by the Harefield Cleansing Scale (HCS). Secondary endpoints included Boston Bowel Preparation Scale (BBPS), endoscopic outcomes, gastric residual volume quantified by esophagogastroduodenoscopy, patient‐reported tolerability, and adverse events. Results: Among 242 per‐protocol participants, HCS‐defined successful cleansing was achieved in 92.7% with 1‐L PEG + low Asc, 100.0% with 1‐L PEG + Asc, and 98.7% with 2‐L PEG + Asc ( p = 0.01). The low‐Asc regimen met noninferiority criteria versus both comparators (risk difference vs. 1‐L PEG + Asc, −7.3%; 97.5% CI, −13.0 to −1.6). BBPS‐defined success, adenoma detection rate (31.7%, 18.1%, and 20.8%), gastric fluid volume (27.4, 28.2, and 25.2 mL), and willingness to repeat the regimen (78.0%, 73.5%, and 71.4%) were similar across groups. Adverse‐event rates were comparable, with no electrolyte disturbances or renal events observed. Conclusions: A modified 1‐L PEG regimen with reduced Asc provides bowel cleansing efficacy noninferior to both standard 1‐L and 2‐L PEG + Asc preparations, with comparable tolerability and safety.Keywords
This publication has 29 references indexed in Scilit:
- Quality indicators for colonoscopyGastrointestinal Endoscopy, 2024
- Improving the tolerability and safety of 1-L polyethylene glycol plus low-dose ascorbic acid for bowel preparation in a healthy population: a randomized multicenter clinical trialGastrointestinal Endoscopy, 2022
- Efficacy and safety of split-dose bowel preparation with 1 L polyethylene glycol and ascorbate compared with 2 L polyethylene glycol and ascorbate in a Korean population: a phase IV, multicenter, randomized, endoscopist-blinded studyGastrointestinal Endoscopy, 2022
- 1 L- versus 2 L-polyethylene glycol with ascorbic acid for bowel preparation in elderly patients: a randomized multicenter studySurgical Endoscopy, 2022
- Efficacy and Tolerability of High- vs Low-Volume Split-Dose Bowel Cleansing Regimens for Colonoscopy: A Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2020
- Evaluation of Clensia ® , a new low-volume PEG bowel preparation in colonoscopy: Multicentre randomized controlled trial versus 4L PEGDigestive and Liver Disease, 2017
- Quality indicators for colonoscopyGastrointestinal Endoscopy, 2015
- Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanlinessGastrointestinal Endoscopy, 2014
- Validation of the Harefield Cleansing Scale: a tool for the evaluation of bowel cleansing quality in both research and clinical practiceGastrointestinal Endoscopy, 2013
- 4-Liter Split-Dose Polyethylene Glycol Is Superior to Other Bowel Preparations, Based on Systematic Review and Meta-analysisClinical Gastroenterology and Hepatology, 2012